How is the Puma Biotechnology Inc today?

The Puma Biotechnology Inc today is trading in the down by -6.18% at 3.19.

How has Puma Biotechnology Inc performed historically?

The Puma Biotechnology Inc is currently trading down -6.18% on an intraday basis in the past week the index fell -4.78%. The index has been down -6.45% in the past quarter and rose 7.05% in the past year. You can view this in the overview section.

What is Puma Biotechnology Inc Annual Revenue?

Puma Biotechnology Inc Annual Revenue fell 2.19%, in the last year to $230.47 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Puma Biotechnology Inc Annual Net Profit?

Puma Biotechnology Inc Annual Net Profit rose 40.23% in the last year to $30.28 M. Its sector's average net profit growth for the last fiscal year was -14.05%.

What is Puma Biotechnology Inc Price to Earning Ratio?

Puma Biotechnology Inc Price to Earning Ratio is 4.16, lower than its sector PE ratio of 4.62.

What is Puma Biotechnology Inc Stock Price?

Puma Biotechnology Inc Stock Price rose 7.05% and underperformed its sector by 148.18% in the past year.

What is Puma Biotechnology Inc Quarterly Revenue?

Puma Biotechnology Inc Quarterly Revenue rose 5.12% YoY to $46.01 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Puma Biotechnology Inc Quarterly Net profit?

Puma Biotechnology Inc Quarterly Net profit rose 161.77% YoY to $2.97 M. Its sector's average net profit growth YoY for the quarter was -236.06%.

What is Puma Biotechnology Inc Debt to Equity Ratio?

Puma Biotechnology Inc Debt to Equity Ratio of 0.8 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Puma Biotechnology Inc Return on Equity(ROE)?

Puma Biotechnology Inc Return on Equity(ROE) for the last financial year was 41.6%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

What is Puma Biotechnology Inc Mutual Fund Holding?

Puma Biotechnology Inc Mutual Fund Holding increased by 2.24% in the last quarter to 35.28.

What is Puma Biotechnology Inc Promoter Share Holding?

Puma Biotechnology Inc Promoter Share Holding increased by 0.25% in the most recent quarter to 20.49%.

What is Puma Biotechnology Inc Interest Coverage Ratio?

Puma Biotechnology Inc Interest Coverage Ratio is 2.94, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Puma Biotechnology Inc Institutional Holding?

Puma Biotechnology Inc Institutional Holding remained the same in the last quarter at 55.78%.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
PUMA BIOTECHNOLOGY INC

Puma Biotechnology Inc XNAS: PBYI

Puma Biotechnology Inc Live Share Price Today, Share Analysis and Chart

Name: Puma Biotechnology Inc: Is Infosys Ltd. worth buying?
Item: Puma Biotechnology Inc
Rating: 3.412347125
Author: Trendlyne DVM scores

Strong Performer

about

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for t...

3.19 -0.21 (-6.18%)

43.69% Gain from 52W Low

311.5K

XNAS Volume

XNAS 20 Jun, 2025 4:04 PM (EDT)

High Financial Strength

72.2 / 100

Affordable Valuation

67.8 / 100

Technically Moderately Bullish

60.7 / 100

Strong Performer These stock companies have strong financials and are affordably priced. They also score high in quality and technical aspects which makes them a favourite amongst investors. View Similar Embed DVM

1Yr Price target downside is -6%

2 analysts

Puma Biotechnology Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Puma Biotechnology Inc Live Share Price Today, Share Analysis and Chart

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for t...

43.69% Gain from 52W Low

SWOT Analysis

Puma Biotechnology Inc Live Price Chart

Puma Biotechnology Inc FAQ

How is Puma Biotechnology Inc today?

Puma Biotechnology Inc today is trading in the red, and is down by -6.18% at 3.19.

How has Puma Biotechnology Inc performed historically?

Puma Biotechnology Inc is currently trading down -6.18% on an intraday basis. In the past week the stock fell -4.78%. stock has been down -6.45% in the past quarter and rose 7.05% in the past year. You can view this in the overview section.